Global Atropine Market, By Type (Injection, Drop, and Gel), By Application (Gastrointestinal, Ophtha

Published Date: | Report Code : CH1930199

X

Global Atropine Market, By Type (Injection, Drop, and Gel), By Application (Gastrointestinal, Ophthalmology, Neurology, Nephrology, and Others), By Region (North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, Rest of the World) – Market Size & Forecasting (2016-2028)

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

Domain : Chemicals

Report Code : CH1930199

Status : Upcoming

The Atropine Market is expected to promise high growth owing to increasing demand in the Asian market in recent years. Increasing demand from applications including gastrointestinal, ophthalmology, neurology, nephrology, and others are expected to drive the growth of the market.

Atropine is synthesized by reducing phenylalanine. Atropine is used as a medication to treat conditions such as pesticide poisoning and nerve agents. It is mainly utilized during surgeries if the heart rate falls suddenly to anaerobic levels or the patient experiences reduced salivary secretions resulting in dry mouth. It is required in high dosages if the patient is antibiotic-resistant. Atropine in high amounts can cause drowsiness, convulsions, coma, and stupor.

Segment Analysis: 

The atropine market is divided into small segments globally with only a few countries producing it while the others procuring it. The atropine market is oligopolistic in nature. Countries such as the US and China are the leaders in global atropine production. Both the US and China combined are responsible for 67%-69% of the global atropine supply.

Due to the low cost of production, less profit margin, and a relatively leaner demand, the global atropine market experienced negative growth between 2013 and 2017. This led to a shortage of atropine supply globally. Many companies shut down the production of atropine due to losses.

The C2 PHARMA is the leading manufacturer of atropine accounting for approximately 10% of the total market share.

Key Factors Impacting Market Growth:

  • Increasing demand in the Asian market
  • Decreasing demand in the Western European market
  • Falling demand due to lethal side effects

Regional Analysis: 

On the basis of the region, the atropine market has been segmented by North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, & Rest of the World. North America and Western Europe are some of the major markets that are also traditional suppliers of chemicals such as specialty chemicals, bulk chemicals, and so on. Major companies in this market are headquartered in North America and Western Europe.  This region has been witnessing a number of transitions in terms of productions of chemicals and respective applications by end-use industries. The preference towards bio-based feedstock has been instrumental in the development of the green alternatives in these regions. Moreover, regulatory authorities have imposed strict guidelines with regard to environmental concerns and potential health hazards due to exposures. This has been more instrumental in the Western Europe region competitively. Some of the major economies in these regions include the US, Germany, UK, France, Canada, Italy, Spain, and so on.

The Asia Pacific and the Middle East are expected to register substantial growth in the atropine market during the forecast period. This demand is with regard to the growth of major end-use industries/Applications such as gastrointestinal, ophthalmology, neurology, nephrology, and others. Major countries in the Asia Pacific region include China, South Korea, Japan, India, Australia, and so on. Middle East includes the UAE, Saudi Arabia, Iran, Israel, Egypt, and so on. Eastern Europe has been largely dominated by Russia and Turkey with operations of major chemical giants in the region.  Rest the World that includes South America and Africa has a strong potential for the atropine market. There has been an increasing number of investments by global companies in these regions to strengthen their presence and tap the potential market. Major economies in these regions for the atropine market include Brazil, South Africa, Nigeria, Argentina, Colombia, and others.

Companies Covered: C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng Group, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International, SAURAV CHEMICALS, Katsura Chemical, Hangzhou Vega, and Wuhan Senwayer Century

Market Segmentation:

By Type:

  • Injection
  • Drop
  • Gel

By Application:

  • Gastrointestinal
  • Ophthalmology
  • Neurology
  • Nephrology
  • Others

By Region:

  • North America
    • By Country (US, Canada, Mexico)
    • By Type
    • By Application
  • Western Europe
    • By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
    • By Type
    • By Application
  • Eastern Europe
    • By Country (Russia, Turkey, Rest of Eastern Europe)
    • By Type
    • By Application
  • Asia Pacific
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Type
    • By Application
  • Middle East
    • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
    • By Type
    • By Application
  • Rest of the World
    • By Region (South America, Africa)
    • By Type
    • By Application

 Reasons to Buy This Report:

  • Market size estimation of the global atropine market on a regional and global basis
  • The unique research design for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: [email protected]

License Offering

Single User (PDF)

3850

Multi User (PDF)

5150

Enterprise User (PDF)

7650

Get Regional Report @ USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy